Natixis Advisors, L.P. Merck & Co., Inc. Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,639,214 shares of MRK stock, worth $136 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
1,639,214
Previous 1,231,846
33.07%
Holding current value
$136 Million
Previous $140 Million
16.57%
% of portfolio
0.3%
Previous 0.27%
Shares
30 transactions
Others Institutions Holding MRK
# of Institutions
3,946Shares Held
1.93BCall Options Held
15.9MPut Options Held
14.9M-
Vanguard Group Inc Valley Forge, PA251MShares$20.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$6.7 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.08 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $210B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...